These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 8833654

  • 21. NFE, a new transcriptional activator that facilitates p50 and c-Rel-dependent IgH 3' enhancer activity.
    Linderson Y, Cross D, Neurath MF, Pettersson S.
    Eur J Immunol; 1997 Feb; 27(2):468-75. PubMed ID: 9045919
    [Abstract] [Full Text] [Related]

  • 22. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
    Crenon I, Béraud C, Simard P, Montagne J, Veschambre P, Jalinot P.
    Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
    [Abstract] [Full Text] [Related]

  • 23. De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor.
    Schjerven H, Tran TN, Brandtzaeg P, Johansen FE.
    J Immunol; 2004 Aug 01; 173(3):1849-57. PubMed ID: 15265917
    [Abstract] [Full Text] [Related]

  • 24. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
    Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE.
    J Clin Invest; 1997 Dec 15; 100(12):2952-60. PubMed ID: 9399940
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms for inducible control of angiotensinogen gene transcription.
    Brasier AR, Li J.
    Hypertension; 1996 Mar 15; 27(3 Pt 2):465-75. PubMed ID: 8613188
    [Abstract] [Full Text] [Related]

  • 26. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
    Müller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Schneider W, Gulba D, Ganten D, Haller H, Luft FC.
    Am J Pathol; 2000 Jul 15; 157(1):111-22. PubMed ID: 10880382
    [Abstract] [Full Text] [Related]

  • 27. Transcriptional regulation of angiotensinogen gene expression.
    Brasier AR, Han Y, Sherman CT.
    Vitam Horm; 1999 Jul 15; 57():217-47. PubMed ID: 10232051
    [Abstract] [Full Text] [Related]

  • 28. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
    Beg AA, Baldwin AS.
    Oncogene; 1994 May 15; 9(5):1487-92. PubMed ID: 8152812
    [Abstract] [Full Text] [Related]

  • 29. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter.
    Catron KM, Brickwood JR, Shang C, Li Y, Shannon MF, Parks TP.
    Cell Growth Differ; 1998 Nov 15; 9(11):949-59. PubMed ID: 9831247
    [Abstract] [Full Text] [Related]

  • 30. Involvement of NF-kappaB p50/p65 heterodimer in activation of the human pro-interleukin-1beta gene at two subregions of the upstream enhancer element.
    Goto M, Katayama KI, Shirakawa F, Tanaka I.
    Cytokine; 1999 Jan 15; 11(1):16-28. PubMed ID: 10080875
    [Abstract] [Full Text] [Related]

  • 31. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes.
    Huang YH, Wu JY, Zhang Y, Wu MX.
    Oncogene; 2002 Oct 03; 21(44):6819-28. PubMed ID: 12360408
    [Abstract] [Full Text] [Related]

  • 32. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors.
    Han Y, Runge MS, Brasier AR.
    Circ Res; 1999 Apr 02; 84(6):695-703. PubMed ID: 10189357
    [Abstract] [Full Text] [Related]

  • 33. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
    Ballard DW, Dixon EP, Peffer NJ, Bogerd H, Doerre S, Stein B, Greene WC.
    Proc Natl Acad Sci U S A; 1992 Mar 01; 89(5):1875-9. PubMed ID: 1542686
    [Abstract] [Full Text] [Related]

  • 34. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization.
    Quinlan KL, Naik SM, Cannon G, Armstrong CA, Bunnett NW, Ansel JC, Caughman SW.
    J Immunol; 1999 Nov 15; 163(10):5656-65. PubMed ID: 10553096
    [Abstract] [Full Text] [Related]

  • 35. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
    Weih F, Carrasco D, Bravo R.
    Oncogene; 1994 Nov 15; 9(11):3289-97. PubMed ID: 7936653
    [Abstract] [Full Text] [Related]

  • 36. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-kappa B activation.
    Bierhaus A, Hemmer CJ, Mackman N, Kutob R, Ziegler R, Dietrich M, Nawroth PP.
    Thromb Haemost; 1995 Jan 15; 73(1):39-48. PubMed ID: 7740494
    [Abstract] [Full Text] [Related]

  • 37. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
    Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ.
    Clin Cancer Res; 1999 Jan 15; 5(1):119-27. PubMed ID: 9918209
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms.
    Ruiz-Ortega M, Lorenzo O, Rupérez M, König S, Wittig B, Egido J.
    Circ Res; 2000 Jun 23; 86(12):1266-72. PubMed ID: 10864918
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.
    Bellas RE, FitzGerald MJ, Fausto N, Sonenshein GE.
    Am J Pathol; 1997 Oct 23; 151(4):891-6. PubMed ID: 9327720
    [Abstract] [Full Text] [Related]

  • 40. Transcriptional activation of the chicken lysozyme gene by NF-kappa Bp65 (RelA) and c-Rel, but not by NF-kappa Bp50.
    Phi van L.
    Biochem J; 1996 Jan 01; 313 ( Pt 1)(Pt 1):39-44. PubMed ID: 8546707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.